Summit Therapeutics’ (SMMT) Operational Momentum Sparks Market Interest

Summit Therapeutics Inc. (NASDAQ: SMMT) announced its financial and operational developments before to the start of trading on Wednesday, which caused a significant spike in the company’s stock on the US stock charts. SMMT shares had a noteworthy 19.59% increase during normal trading hours, ending at $4.70. Summit Therapeutics (SMMT) unveiled its financial outcomes and […]